logo
GeoPark Reports Second Quarter 2025 Results

GeoPark Reports Second Quarter 2025 Results

Business Wirea day ago
BOGOTA, Colombia--(BUSINESS WIRE)--GeoPark Limited ('GeoPark' or the 'Company') (NYSE: GPRK), a leading independent energy company with over 20 years of successful operations across Latin America, reports its consolidated financial results for the three-month period ended June 30, 2025 ('Second Quarter' or '2Q2025'). A conference call to discuss these financial results will be held on August 6, 2025, at 10:00 am (Eastern Daylight Time).
GeoPark delivered solid financial and operational results in 2Q2025, despite a lower oil price environment. Strong execution, proactive cost management and disciplined capital allocation supported results, while enabling continued investment in high-return projects within the Company's core portfolio. Consistent with its strategic priorities, GeoPark focused on strengthening its balance sheet and protecting financial flexibility to navigate a lower oil price environment and position the Company for long-term, value-accretive growth.
SECOND QUARTER 2025 FINANCIAL SUMMARY
In 2Q2025, GeoPark reported Adjusted EBITDA 1 of $71.5 million (60% margin), a 19% decrease compared to 1Q2025, mainly due to a 9% drop in realized prices and a 6% decrease in production volumes, partially offset by an 8% reduction in production and operating costs, which remained at $12.3 per barrel of produced boe.
Net loss for the quarter totaled $10.3 million compared to a $13.1 million profit in 1Q2025, primarily reflecting a non-recurring impairment charge related to the divestment of assets in Ecuador. As part of its ongoing portfolio review, GeoPark agreed to divest its 50% working interest ('WI') in the Perico and Espejo Blocks in Ecuador for a total cash consideration of $7.8 million. The closing of the divestment transaction is subject to regulatory approvals. 2
Excluding the non-recurring impairment, net profit for the quarter amounted to $20.7 million, 58% higher than 1Q2025, reflecting lower depreciation, financial expenses and income tax. The effective tax rate for 2Q2025 was 27%, below the statutory income tax rate of 35% in Colombia, primarily due to the re-estimation of the oil and gas sector surcharge, which was reduced from 5% to 0% in response to the lower oil price environment.
Capital expenditures in 2Q2025 totaled $23.9 million, primarily directed toward the execution of the integrated drilling and workover campaign in the Llanos 34 Block (GeoPark operated, 45% WI), enhancing operational efficiency and maintaining stable production levels. In parallel, an exploration and appraisal campaign continued in the Llanos 123 Block (GeoPark operated, 50% WI), supported by the construction of key infrastructure.
At the end of the second quarter, the Company had $266.0 million cash in hand, while net debt stood at $359.5 million with a low leverage ratio of 1.1x, reflecting a robust capital structure.
To mitigate downside risk from oil price volatility, the Company continues to proactively manage its hedging strategy. For 2025, approximately 87% of expected production is hedged with price floors between $68–70/bbl, resulting in a $4.9 million gain reflected in 2Q2025 revenue. As of August 5, 2025, oil price protection for 2026 has also been secured through 3-way collars, for approximately 9,000 boepd of 1H2026 and 8,000 boepd of 2H2026 production, with average strike prices at $50/$65/$74.
Reflecting the Company's performance during the quarter, the Board of Directors declared a quarterly cash dividend of $0.147 per share (approximately $7.5 million), payable on September 4, 2025. In parallel, the Board is actively reviewing the Company's capital allocation priorities, including dividend distribution going forward in the context of evolving strategic priorities and the need to preserve flexibility to pursue value-accretive growth opportunities. This review will continue over the coming months as part of our ongoing overall financial and strategic positioning.
COST AND CAPITAL EFFICIENCY MEASURES
GeoPark is implementing several cost and capital efficiency initiatives to further enhance value and maximize long term competitiveness. These initiatives also reflect the Company's clear intent to preserve financial firepower for ongoing inorganic growth initiatives, while navigating continued Brent price volatility. The measures are the following:
Cost Efficiencies
The Company has implemented a comprehensive efficiency program to align the cost structure with current activity levels. The goal is to ensure a competitive organization that maximizes value from the existing portfolio, while preserving the distinctive capabilities necessary to pursue long term reserves renewal and incremental shareholder value. By the end of July 2025, the Company had already captured $12.5 million in efficiencies. On an annualized basis, such efficiencies represent approximately $17.5 million of structural savings going forward.
Debt Reduction
Underscoring its disciplined approach to capital allocation and balance sheet optimization, the Company repurchased $54.5 million of its 2030 Notes in June and July 2025 at an average price of $0.88 and $0.89 on the dollar, respectively, through open market transactions. These repurchases generate coupon savings of approximately $5 million annually (or over $20 million until the Notes' maturity in 2030) while enhancing long-term financial flexibility. The Company will continue to actively monitor market conditions to opportunistically pursue further value-accretive liability management initiatives, subject to available liquidity and overall capital allocation priorities.
Felipe Bayon, Chief Executive Officer of GeoPark, said: 'My first two months at GeoPark have been an intense and rewarding period of learning, listening, and engaging closely with our teams and operations. I have encountered a company with a very solid operating platform and a deeply committed team, and these strong foundations have allowed us to continue delivering resilient results, despite today's complex and volatile environment. Our second quarter results were slightly ahead of our existing guidance, and we are actively reassessing our portfolio and cost structure, prioritizing capital allocation, divesting non-core assets and exploring new organic and inorganic opportunities to generate value. With focus, agility, and the right decisions, I'm confident we can write GeoPark's next growth chapter.'
Supplementary information is available at the following link: https://ir.geo-park.com/2Q25-SupplementaryRelease
SECOND QUARTER 2025 HIGHLIGHTS
Oil and Gas Production and Operations
2Q2025 consolidated average oil and gas production of 27,380 boepd 3, reflecting solid delivery from core assets
Year-to-date consolidated average oil and gas production of 28,223 boepd
5 rigs in operation (1 drilling and 4 workover) at the end of 2Q2025
Divestment of the 50% WI in the Perico and Espejo Blocks in Ecuador
Revenue, Adjusted EBITDA and Net Profit
Revenue of $119.8 million, impacted by lower realized oil prices and volumes associated with divestments and downtime
Adjusted EBITDA of $71.5 million with a 60% margin, reflecting cost discipline and hedge gains
Operating profit of $7.1 million (including the effect of the non-recurring impairment in Ecuador)
Effective tax rate of 27% in 2Q2025 (excluding the effect of the non-recurring impairment in Ecuador), reflecting a 0% oil sector surcharge in Colombia resulting from lower oil prices
Net loss of $10.3 million ($0.20 basic losses per share)
Cost and Capital Efficiency
Capital expenditures of $23.9 million, focused on workovers and exploration campaigns
2Q2025 Adjusted EBITDA to capital expenditures ratio of 3.0x
ROACE of 26% 4
Operating costs per produced boe of $12.3
$12.5 million captured in efficiencies by the end of July
Balance Sheet and Liquidity
Cash in hand of $266.0 million
Full-Year net leverage of 1.1x and no principal debt maturities until January 2027
During June-July, successfully completed open market repurchases of $54.5 million in aggregate principal of the 2030 Notes below par, generating a $5.0 million gain and annual cash coupon savings of $5 million
Hedging and Risk Management
87% of expected 2025 production hedged with Brent floors between $68–70/bbl
$4.9 million gain from commodity risk management contracts recognized in 2Q2025 revenue
As of August 5, 2025, approximately 9,000 boepd of 1H2026 and 8,000 boepd of 2H2026 expected production has been protected through 3-way collars with average strikes of $50/$65/$74
Shareholder Value Return
Quarterly cash dividend of $0.147 per share, or approximately $7.5 million, payable on September 4, 2025, to shareholders of record at the close of business on August 19, 2025
The Board of Directors is actively reviewing the Company's capital allocation priorities, including dividend distribution going forward, to ensure alignment with evolving strategic priorities and maintain flexibility for future growth
2025 Annual General Meeting
GeoPark's 2025 Annual General Meeting, initially convened on July 30, 2025, did not reach the required quorum and therefore will resume on August 6, 2025, at 10:00 a.m. (Bermuda time)
The agenda, proxy materials, and voting procedures remain unchanged. Shareholders of record as of June 10, 2025, will continue to be entitled to vote at the reconvened meeting
___________________
1
For reconciliations, see 'Reconciliation of Adjusted EBITDA to Profit Before Income Tax' table below.
2
The agreement includes an additional contingent consideration of $750,000, payable upon the Perico Block achieving cumulative gross production of two million barrels as from January 1, 2025. The total firm consideration is subject to working capital and other customary adjustments. The divested assets had 1.6 million barrels of net 2P reserves as of year-end 2024 (2% of GeoPark's 2P reserves) and delivered an average gross production of ~2,000 boepd during July (~1,000 boepd net), or 4% of GeoPark's production.
3
Reported in the 2Q2025 Operational Update.
4
ROACE is defined as last twelve-month operating profit divided by average capital employed. Capital employed is calculated as total assets minus current liabilities and adjusted for excess cash. Excess cash corresponds to the portion of cash and cash equivalents that exceeds the amount required to cover current liabilities with current assets. The non-recurring impairment charge related to the divestment of assets in Ecuador was excluded from operating profit for the purpose of this calculation.
Expand
Key performance indicators:
Key Indicators
2Q2025
1Q2025
2Q2024
1H2025
1H2024
Oil production a (bopd)
27,151
28,972
35,504
28,056
34,880
Gas production (mcfpd)
1,371
624
623
999
3,964
Average net production (boepd)
27,380
29,076
35,608
28,223
35,540
Brent oil price ($ per bbl)
66.8
74.9
85.0
70.8
83.4
Combined realized price b ($ per boe)
57.4
62.8
72.0
60.2
68.6
⁻ Oil c ($ per bbl)
57.5
65.3
74.9
61.5
72.3
⁻ Gas ($ per mcf)
5.8

8.9
5.8
5.7
Sale of crude oil ($ million)
114.2
137.1
187.2
251.4
349.4
Sale of purchased crude oil ($ million)

0.4
2.4
0.4
4.2
Sale of gas ($ million)
0.7

0.6
0.7
4.1
Commodity risk management contracts ($ million)
4.9
(0.2
)

4.7
(0.1
)
Revenue ($ million)
119.8
137.3
190.2
257.1
357.6
Production & operating costs d ($ million)
(32.6
)
(35.4
)
(41.4
)
(68.0
)
(80.0
)
G&G, G&A e ($ million)
(12.1
)
(11.5
)
(16.0
)
(23.6
)
(28.7
)
Selling expenses ($ million)
(3.0
)
(2.2
)
(4.4
)
(5.1
)
(8.5
)
Operating profit ($ million)
7.1
50.4
90.3
57.5
174.3
Adjusted EBITDA ($ million)
71.5
87.9
127.9
159.5
239.4
Adjusted EBITDA ($ per boe)
34.3
40.2
48.4
37.3
45.9
Net (loss) profit ($ million)
(10.3
)
13.1
25.7
2.7
55.9
Capital expenditures ($ million)
23.9
22.6
49.2
46.6
98.0
Cash and cash equivalents ($ million)
266.0
308.0
66.0
266.0
66.0
Short-term financial debt ($ million)
30.8
19.0
12.5
30.8
12.5
Long-term financial debt ($ million)
594.8
638.4
490.2
594.8
490.2
Net debt ($ million)
359.5
349.4
436.7
359.5
436.7
Dividends paid ($ per share)
0.147
0.147
0.147
0.294
0.283
Shares repurchased (million shares)


4.369

4.369
Basic shares – at period end (million shares)
51,568
51,318
51,163
51,568
51,163
Weighted average basic shares (million shares)
51,529
51,281
52,246
51,405
53,787
Expand
a)
Includes royalties and other economic rights paid in kind in Colombia for approximately 4,236 bopd, 4,869 bopd, and 6,956 bopd in 2Q2025, 1Q2025 and 2Q2024, respectively. No royalties were paid in kind in other countries. Production in Ecuador is reported before the Government's production share.
b)
After the effect of earn-out to ex-owners of certain blocks.
c)
Before the effect of earn-out to ex-owners of certain blocks.
d)
Production and operating costs include operating costs, royalties and economic rights paid in cash, share-based payments and purchased crude oil.
e)
G&A and G&G expenses include non-cash, share-based payments for $0.9 million, $1.4 million, and $1.3 million in 2Q2025, 1Q2025 and 2Q2024, respectively. These expenses are excluded from the Adjusted EBITDA calculation.
Expand
All figures are expressed in US Dollars and growth comparisons refer to the same period of the prior year, except when specified. Definitions and terms used herein are provided in the Glossary at the end of this document. This press release and its supplementary information do not contain all the Company's financial information and the Company's consolidated financial statements and corresponding notes for the period are available on the Company's website.
1H2025 (In millions of $)
Colombia
Ecuador
Brazil
Other (a)
Total
Adjusted EBITDA
161.3
5.3
(2.4
)
(4.8
)
159.5
Depreciation
(56.6
)
(4.1
)
(0.2
)

(61.0
)
Write-offs
(5.9
)



(5.9
)
Impairment

(31.0
)


(31.0
)
Share based payment
(0.4
)
(0.0
)
(0.0
)
(2.1
)
(2.6
)
Lease Accounting - IFRS 16
2.5
0.0
0.5

2.9
Others
0.4
(0.3
)
(0.6
)
(4.0
)
(4.4
)
OPERATING PROFIT (LOSS)
101.3
(30.1
)
(2.8
)
(10.9
)
57.5
Financial costs, net
(31.5
)
Foreign exchange charges, net
(3.3
)
PROFIT BEFORE INCOME TAX
22.8
1H2024 (In millions of $)
Colombia
Ecuador
Brazil
Other (a)
Total
Adjusted EBITDA
238.9
6.5
(0.8
)
(5.2
)
239.4
Depreciation
(59.1
)
(3.0
)
(0.9
)
(0.0
)
(63.0
)
Write-offs
(3.4
)



(3.4
)
Share based payment
(0.6
)
(0.0
)
(0.0
)
(2.6
)
(3.2
)
Lease Accounting - IFRS 16
3.2
0.0
0.5

3.6
Others
0.9
0.1
0.0
(0.3
)
0.8
OPERATING PROFIT (LOSS)
179.9
3.6
(1.2
)
(8.0
)
174.3
Financial costs, net
(17.8
)
Foreign exchange charges, net
6.1
PROFIT BEFORE INCOME TAX
162.6
Expand
(a)
Includes Chile (in 1H2024), Argentina and Corporate business.
Expand
CONFERENCE CALL INFORMATION
GeoPark management will host a conference call on Wednesday, August 6, 2025, at 10:00 am (Eastern Daylight Time) to discuss the 2Q2025 financial results.
To listen to the call, participants can access the webcast located in the Invest with Us section of the Company's website at www.geo-park.com, or by clicking below:
https://events.q4inc.com/attendee/211725993
Interested parties may participate in the conference call by dialing the numbers provided below:
United States Participants: +1 404-975-4839
Global Dial-In Numbers:
Passcode: 553033
Please allow extra time prior to the call to visit the website and download any streaming media software that might be required to listen to the webcast.
An archive of the webcast replay will be made available in the Invest with Us section of the Company's website at www.geo-park.com after the conclusion of the live call.
NOTICE
Additional information about GeoPark can be found in the Invest with Us section of the website at www.geo-park.com.
Rounding amounts and percentages: Certain amounts and percentages included in this press release and its supplementary information have been rounded for ease of presentation. Percentage figures included in this press release and its supplementary information have not in all cases been calculated on the basis of such rounded figures, but on the basis of such amounts prior to rounding. In addition, certain other amounts that appear in this press release and its supplementary information may not sum due to rounding.
This press release and its supplementary information contain certain oil and gas metrics, including information per share, operating netback, reserve life index and others, which do not have standardized meanings or standard methods of calculation and therefore such measures may not be comparable to similar measures used by other companies. Such metrics have been included herein to provide readers with additional measures to evaluate the Company's performance; however, such measures are not reliable indicators of the future performance of the Company and future performance may not compare to the performance in previous periods.
CAUTIONARY STATEMENTS RELEVANT TO FORWARD-LOOKING INFORMATION
This press release and its supplementary information contain statements that constitute forward-looking statements. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as ''anticipate,'' ''believe,'' ''could,'' ''expect,'' ''should,'' ''plan,'' ''intend,'' ''will,'' ''estimate'' and ''potential,'' among others.
Forward-looking statements that appear in a number of places in this press release include, but are not limited to, statements regarding the intent, belief or current expectations, regarding various matters, including liability management initiatives, hedging of expected production, full year net leverage figures, strategic initiatives, growth and capital allocation, and the divestment transaction in Ecuador. Forward-looking statements are based on management's beliefs and assumptions, and on information currently available to the management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors.
Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances, or to reflect the occurrence of unanticipated events. For a discussion of the risks facing the Company which could affect whether these forward-looking statements are realized, see filings with the U.S. Securities and Exchange Commission (SEC).
Oil and gas production figures included in this press release and its supplementary information are stated before the effect of royalties paid in kind, consumption and losses. Annual production per day is obtained by dividing total production by 365 days.
Non-GAAP Measures: The Company believes Adjusted EBITDA, free cash flow and operating netback per boe, which are each non-GAAP measures, are useful because they allow the Company to more effectively evaluate its operating performance and compare the results of its operations from period to period without regard to its financing methods or capital structure. The Company's calculation of Adjusted EBITDA, free cash flow, and operating netback per boe may not be comparable to other similarly titled measures of other companies.
Adjusted EBITDA: The Company defines Adjusted EBITDA as profit for the period before net finance costs, income tax, depreciation, amortization and certain non-cash items such as impairments and write-offs of unsuccessful exploration and evaluation assets, accrual of stock options and stock awards, unrealized results on commodity risk management contracts and other non-recurring events. Adjusted EBITDA is not a measure of profit or cash flow as determined by IFRS. The Company excludes the items listed above from profit for the period in arriving at Adjusted EBITDA because these amounts can vary substantially from company to company within our industry depending upon accounting methods and book values of assets, capital structures and the method by which the assets were acquired. Adjusted EBITDA should not be considered as an alternative to, or more meaningful than, profit for the period or cash flow from operating activities as determined in accordance with IFRS or as an indicator of our operating performance or liquidity. Certain items excluded from Adjusted EBITDA are significant components in understanding and assessing a company's financial performance, such as a company's cost of capital and tax structure and significant and/or recurring write-offs, as well as the historic costs of depreciable assets, none of which are components of Adjusted EBITDA. For a reconciliation of Adjusted EBITDA to the IFRS financial measure of profit, see the accompanying financial tables and the supplementary information.
Operating Netback per boe: Operating netback per boe should not be considered as an alternative to, or more meaningful than, profit for the period or cash flow from operating activities as determined in accordance with IFRS or as an indicator of the Company's operating performance or liquidity. Certain items excluded from operating netback per boe are significant components in understanding and assessing a company's financial performance, such as a company's cost of capital and tax structure and significant and/or recurring write-offs, as well as the historic costs of depreciable assets, none of which are components of operating netback per boe. The Company's calculation of operating netback per boe may not be comparable to other similarly titled measures of other companies.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The three-year shareholder returns and company earnings persist lower as Bath & Body Works (NYSE:BBWI) stock falls a further 6.5% in past week
The three-year shareholder returns and company earnings persist lower as Bath & Body Works (NYSE:BBWI) stock falls a further 6.5% in past week

Yahoo

time10 minutes ago

  • Yahoo

The three-year shareholder returns and company earnings persist lower as Bath & Body Works (NYSE:BBWI) stock falls a further 6.5% in past week

Many investors define successful investing as beating the market average over the long term. But if you try your hand at stock picking, you risk returning less than the market. Unfortunately, that's been the case for longer term Bath & Body Works, Inc. (NYSE:BBWI) shareholders, since the share price is down 20% in the last three years, falling well short of the market return of around 57%. Even worse, it's down 13% in about a month, which isn't fun at all. After losing 6.5% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the three years that the share price fell, Bath & Body Works' earnings per share (EPS) dropped by 4.3% each year. This reduction in EPS is slower than the 7% annual reduction in the share price. So it seems the market was too confident about the business, in the past. The less favorable sentiment is reflected in its current P/E ratio of 7.50. You can see below how EPS has changed over time (discover the exact values by clicking on the image). We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. It might be well worthwhile taking a look at our free report on Bath & Body Works' earnings, revenue and cash flow. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Bath & Body Works, it has a TSR of -14% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 23% in the last year, Bath & Body Works shareholders lost 6.3% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 8%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Bath & Body Works better, we need to consider many other factors. Take risks, for example - Bath & Body Works has 3 warning signs (and 1 which can't be ignored) we think you should know about. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

BiVACOR Total Artificial Heart Accepted into FDA's Total Product Life Cycle (TAP) Program
BiVACOR Total Artificial Heart Accepted into FDA's Total Product Life Cycle (TAP) Program

Business Wire

time11 minutes ago

  • Business Wire

BiVACOR Total Artificial Heart Accepted into FDA's Total Product Life Cycle (TAP) Program

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical device company developing the world's first titanium Total Artificial Heart (TAH), today announced that its TAH System has been accepted into the U.S. Food and Drug Administration's (FDA) prestigious Total Product Life Cycle (TPLC) Advisory Program, also known as the TAP program. This milestone further solidifies BiVACOR's collaboration with the FDA following the TAH's earlier recognition this year as a Breakthrough Device. This isn't just a vote of confidence in BiVACOR, it's a vote of confidence in the future of heart replacement technology. The TAP program gives us the opportunity to collaborate with the FDA at a level that aligns with urgency and magnitude of our mission. Share The TAP program is a transformative FDA initiative designed to accelerate the development and patient access to high-impact medical technologies. Entry into the program provides BiVACOR with proactive, strategic engagement with the FDA throughout the entire product life cycle, from development to commercialization, supporting more efficient, risk-informed decision-making. TAP participation is reserved for breakthrough-designated devices with the potential to significantly improve patient outcomes for serious or life-threatening conditions. 'Acceptance into the TAP program marks a major milestone not just for BiVACOR, but for the field of mechanical circulatory support as a whole,' said Daniel Timms, Founder and Chief Technology Officer of BiVACOR. 'The BiVACOR TAH has the potential to fundamentally redefine the standard of care for patients with end-stage heart failure. TAP access gives us a powerful framework for working hand-in-hand with the FDA to bring this technology to the patients who need it most.' The BiVACOR TAH is intended for use as a bridge to transplant in adults with severe, irreversible biventricular or univentricular heart failure, particularly for patients who cannot be treated with traditional left ventricular assist devices (LVADs). The system employs a magnetically levitated centrifugal pump, inspired by space and industrial technologies, which provides continuous, pulsatile, and physiologically responsive cardiac support. The FDA's acceptance letter to BiVACOR emphasized that the TAP program's inclusion reflects the agency's confidence in the technology's potential to transform clinical practice. As part of the program, BiVACOR will receive more regulatory guidance, earlier identification of scientific and evidentiary gaps, and greater coordination among stakeholders, including payers and patient advocacy groups. 'This isn't just a vote of confidence in BiVACOR, it's a vote of confidence in the future of heart replacement technology,' said William Cohn, MD, BiVACOR Chief Medical Officer and renowned cardiac surgeon. 'The TAP program gives us the opportunity to collaborate with the FDA at a level that aligns with the urgency and magnitude of our mission to bring a durable, fully implantable artificial heart to patients with no other options.' The TAP program was established as part of the FDA's efforts to modernize device development oversight and ensure the U.S. remains at the forefront of medical innovation. The program currently operates as a pilot under the Center for Devices and Radiological Health (CDRH), with acceptance based on strict criteria outlined in the Federal Register (87 FR 61605). BiVACOR's participation in TAP follows several recent milestones for the company, including its first-in-human implant as a bridge to support a patient awaiting a cardiac transplant. The company is now progressing toward expanded clinical trials in the U.S. and internationally. For more information on the FDA's TAP program, visit: Participation in the FDA's Total Product Life Cycle Advisory Program (TAP) does not imply FDA approval, clearance, or authorization. Inclusion in the TAP Pilot does not guarantee future marketing authorization or a regulatory outcome. The BiVACOR TAH is currently used as an investigational device and is not approved for commercial use. About BiVACOR BiVACOR ® is a clinical-stage medical device company developing a fully implantable, magnetically levitated Total Artificial Heart for long-term support of patients with end-stage biventricular heart failure. Founded by biomedical engineer Daniel Timms, PhD, and backed by leading experts in cardiovascular medicine including Dr. William E. Cohn and Dr. O.H. (Bud) Frazier, the company is conducting an FDA-approved Early Feasibility Study in the U.S. Headquartered in Huntington Beach, CA, with clinical operations in Houston and engineering offices in Gold Coast, Australia, BiVACOR is committed to addressing the global shortage of donor hearts through advanced, scalable technology. Learn more at

Assurant (AIZ) Shares Skyrocket, What You Need To Know
Assurant (AIZ) Shares Skyrocket, What You Need To Know

Yahoo

time33 minutes ago

  • Yahoo

Assurant (AIZ) Shares Skyrocket, What You Need To Know

What Happened? Shares of insurance services company Assurant (NYSE:AIZ) jumped 10.6% in the afternoon session after the company reported strong second-quarter financial results that surpassed expectations and raised its full-year outlook. The specialty insurance provider posted adjusted earnings of $5.56 per share, which handily topped analyst estimates of $4.43. Revenue also grew 8% from the prior year to $3.16 billion. The strong performance stemmed from growth across its Global Housing and Global Lifestyle divisions. Buoyed by the strong first half of the year, Assurant increased its 2025 financial outlook. The company now expected adjusted earnings per share to approach 10% growth for the full year. Is now the time to buy Assurant? Access our full analysis report here, it's free. What Is The Market Telling Us Assurant's shares are not very volatile and have only had 4 moves greater than 5% over the last year. Moves this big are rare for Assurant and indicate this news significantly impacted the market's perception of the business. Assurant is down 0.6% since the beginning of the year, but at $210.05 per share, it is still trading close to its 52-week high of $228.68 from November 2024. Investors who bought $1,000 worth of Assurant's shares 5 years ago would now be looking at an investment worth $1,767. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store